Piramal Imaging announced today that the company has settled into a global license agreement with Swiss bioresearch firm AC Immune for further development and commercialization of tau-protein PET agents designed to aid in the diagnosis of neurodegenerative disease, including Alzheimer’s disease (AD).

A recently published study has confirmed that MR-guided focused ultrasound (US) can relieve pain and improve function in most patients with bone tumors who are not candidates for radiation treatment.

Boston-based AG Mednet announced yesterday that the software company would be partnering with board-certified radiologists from Imaging Endpoints to improve the latter's clinical trial submission quality and compliance.

The Centers for Medicare & Medicaid Services (CMS) is projected to publish a final rule on “burdensome” regulations regarding imaging in ambulatory surgical centers (ASC) and radiopharmaceutical preparation in hospitals on May 12.

Navidea Biopharmaceuticals, developers of Lymphoseek and novel NAV4694 announced its first quarter 2014 financial report Wednesday including word of $752,000 revenue over absolutely zero revenue for that period last year.

The Minnesota House of Representatives passed a breast density notification bill this week on a bipartisan vote of 126-7.

A new CARESTREAM DRX-Evolution DR room is the main hub for all general radiology exams at the 232-bed Metroplex Adventist Hospital (Killeen, Texas).

Millions of women each year are diagnosed with breast cancer; but, early detection and treatment are among the most effective ways to overcome cancer and live life to the fullest. FUJIFILM Medical Systems U.S.A., Inc. and the National Breast Cancer Foundation (NBCF)announced today a collaboration that will extend the work of Fujifilm’s Images of Health campaign, aimed at educating and encouraging all women to understand the importance of early detection of breast cancer.